Want to join the conversation?
Pharmaceutical company $ABT said that the FDA has approved the first in a new category of intraocular lenses called Tecnis Symfony for the treatment of cataracts. These lenses provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia, also known as farsightedness.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.